StonvexLoading…
StonvexCore line items from SMRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $40.41M | $38.68M | $152.33M | $115.85M | $79.65M |
Operating Income | Not available | $-5.09M | $-63.98M | $-60.00M | $-52.97M |
Net Income | Not available | $-4.45M | $-60.56M | $-57.31M | $-10.86M |
EPS (Diluted) | $-0.02 | $-0.02 | $-0.32 | $-0.30 | $-0.27 |
Total Assets | Not available | $300.24M | $320.93M | $335.80M | $353.97M |
Total Liabilities | Not available | $69.56M | $88.79M | $101.39M | $115.12M |
Cash & Equivalents | Not available | $98.82M | $104.55M | $100.02M | $105.04M |
Free Cash Flow OCF − CapEx | Not available | $-4.57M | $-25.13M | $-32.78M | $-30.56M |
Shares Outstanding | Not available | 192.72M | 189.68M | 189.20M | 188.06M |